Xolair 300 MG/2 ML autoinject 2ML

Ended Awarded

Contract number
SPE2DR26FMFG5
Awardee
Awarding agency
Obligated
$20,969

Award facts

Contract value 100% obligated
$20,969.28 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a $20,969.28 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on June 25, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for Xolair 300 mg/2 ml autoinjector.

PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities worldwide. Place of performance is Park Ridge, IL. The order has an ultimate completion date of July 17, 2026.

Quick answers

Who was awarded contract SPE2DR26FMFG5?

SPE2DR26FMFG5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 25, 2026.

How much is contract SPE2DR26FMFG5 worth?

The government has obligated $20,969 on SPE2DR26FMFG5.

Is contract SPE2DR26FMFG5 an order under another contract?

Yes. SPE2DR26FMFG5 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.

Was contract SPE2DR26FMFG5 competed?

The extent of competition for SPE2DR26FMFG5 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login